$48.96
+0.13
(+0.27%)▲
Live
Insights on Radnet Inc
Revenue is up for the last 2 quarters, 401.96M → 420.38M (in $), with an average increase of 4.4% per quarter
Netprofit is down for the last 2 quarters, 17.54M → -1.86M (in $), with an average decrease of 110.6% per quarter
0.22%
Downside
Day's Volatility :1.91%
Upside
1.69%
48.71%
Downside
52 Weeks Volatility :49.72%
Upside
1.96%
Period | Radnet Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 29.45% | 1.9% | 0.0% |
6 Months | 73.53% | 10.7% | 0.0% |
1 Year | 75.27% | 4.6% | -1.1% |
3 Years | 119.95% | 14.2% | -22.1% |
Market Capitalization | 3.5B |
Book Value | $9.28 |
Earnings Per Share (EPS) | 0.05 |
PE Ratio | 953.0 |
PEG Ratio | 2.32 |
Wall Street Target Price | 53.33 |
Profit Margin | 0.19% |
Operating Margin TTM | 7.4% |
Return On Assets TTM | 2.37% |
Return On Equity TTM | 4.65% |
Revenue TTM | 1.6B |
Revenue Per Share TTM | 25.43 |
Quarterly Revenue Growth YOY | 9.5% |
Gross Profit TTM | 288.8M |
EBITDA | 225.3M |
Diluted Eps TTM | 0.05 |
Quarterly Earnings Growth YOY | 24.0 |
EPS Estimate Current Year | 0.55 |
EPS Estimate Next Year | 0.76 |
EPS Estimate Current Quarter | 0.15 |
EPS Estimate Next Quarter | -0.08 |
What analysts predicted
Upside of 8.93%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 975.1M | ↑ 5.74% |
Net Income | 32.2M | ↑ 60735.85% |
Net Profit Margin | 3.31% | ↑ 3.3% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 18.36% |
Net Income | 23.4M | ↓ 27.3% |
Net Profit Margin | 2.03% | ↓ 1.28% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 7.13% |
Net Income | -1.7M | ↓ 107.46% |
Net Profit Margin | -0.16% | ↓ 2.19% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 22.69% |
Net Income | 44.3M | ↓ 2633.96% |
Net Profit Margin | 3.37% | ↑ 3.53% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 8.74% |
Net Income | 33.6M | ↓ 24.17% |
Net Profit Margin | 2.35% | ↓ 1.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.6B | ↑ 13.05% |
Net Income | 3.0M | ↓ 90.94% |
Net Profit Margin | 0.19% | ↓ 2.16% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 350.0M | ↓ 1.22% |
Net Income | 6.4M | ↓ 53.39% |
Net Profit Margin | 1.84% | ↓ 2.06% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 383.9M | ↑ 9.66% |
Net Income | 5.0M | ↓ 22.93% |
Net Profit Margin | 1.29% | ↓ 0.55% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 390.6M | ↑ 1.74% |
Net Income | -14.3M | ↓ 387.44% |
Net Profit Margin | -3.66% | ↓ 4.95% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 403.7M | ↑ 3.37% |
Net Income | 8.4M | ↓ 158.59% |
Net Profit Margin | 2.07% | ↑ 5.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 402.0M | ↓ 0.43% |
Net Income | 17.5M | ↑ 109.58% |
Net Profit Margin | 4.36% | ↑ 2.29% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 420.4M | ↑ 4.58% |
Net Income | -1.9M | ↓ 110.6% |
Net Profit Margin | -0.44% | ↓ 4.8% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 27.66% |
Total Liabilities | 909.1M | ↑ 13.77% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 48.34% |
Total Liabilities | 1.4B | ↑ 55.37% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 8.57% |
Total Liabilities | 1.5B | ↑ 8.2% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.1B | ↑ 15.21% |
Total Liabilities | 1.7B | ↑ 12.04% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 18.24% |
Total Liabilities | 1.9B | ↑ 13.44% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 18.6% |
Total Liabilities | 2.1B | ↑ 6.74% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.2B | ↑ 0.29% |
Total Liabilities | 1.8B | ↓ 0.03% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.4B | ↑ 8.31% |
Total Liabilities | 1.9B | ↑ 8.59% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.4B | ↓ 0.82% |
Total Liabilities | 1.9B | ↓ 1.11% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.7B | ↑ 12.06% |
Total Liabilities | 1.9B | ↑ 1.21% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.7B | ↓ 0.64% |
Total Liabilities | 1.9B | ↓ 2.7% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.9B | ↑ 7.39% |
Total Liabilities | 2.1B | ↑ 9.59% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 116.8M | ↓ 17.31% |
Investing Cash Flow | -146.7M | ↑ 85.01% |
Financing Cash Flow | -10.9M | ↓ 66.29% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 104.3M | ↓ 10.65% |
Investing Cash Flow | -99.5M | ↓ 32.22% |
Financing Cash Flow | 25.0M | ↓ 329.56% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 233.8M | ↑ 124.07% |
Investing Cash Flow | -126.2M | ↑ 26.92% |
Financing Cash Flow | -45.6M | ↓ 282.6% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 149.5M | ↓ 36.05% |
Investing Cash Flow | -221.5M | ↑ 75.46% |
Financing Cash Flow | 104.7M | ↓ 329.74% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 146.4M | ↓ 2.06% |
Investing Cash Flow | -246.9M | ↑ 11.48% |
Financing Cash Flow | 93.6M | ↓ 10.53% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 27.0M | ↓ 58.32% |
Investing Cash Flow | -27.1M | ↓ 21.39% |
Financing Cash Flow | -3.3M | ↑ 0.03% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 53.6M | ↑ 98.5% |
Investing Cash Flow | -123.9M | ↑ 357.88% |
Financing Cash Flow | 103.6M | ↓ 3226.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 32.6M | ↓ 39.2% |
Investing Cash Flow | -65.6M | ↓ 47.09% |
Financing Cash Flow | -3.8M | ↓ 103.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 68.1M | ↑ 108.72% |
Investing Cash Flow | -40.4M | ↓ 38.44% |
Financing Cash Flow | 238.1M | ↓ 6331.95% |
Sell
Neutral
Buy
Radnet Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Radnet Inc | 3.83% | 73.53% | 75.27% | 119.95% | 298.61% |
Idexx Laboratories, Inc. | -6.78% | 14.63% | -1.95% | -11.57% | 119.88% |
Agilent Technologies Inc. | -4.37% | 31.77% | 0.52% | 1.35% | 83.67% |
Thermo Fisher Scientific, Inc. | 0.18% | 25.39% | 0.05% | 16.3% | 119.68% |
Danaher Corp. | 2.14% | 28.59% | -0.49% | -1.93% | 95.75% |
Iqvia Holdings Inc. | -4.12% | 27.82% | 17.55% | 2.23% | 75.73% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Radnet Inc | 953.0 | 953.0 | 2.32 | 0.55 | 0.05 | 0.02 | NA | 9.28 |
Idexx Laboratories, Inc. | 47.62 | 47.62 | 4.75 | 11.13 | 0.81 | 0.23 | NA | 17.88 |
Agilent Technologies Inc. | 32.04 | 32.04 | 2.7 | 5.5 | 0.21 | 0.08 | 0.01 | 21.12 |
Thermo Fisher Scientific, Inc. | 35.47 | 35.47 | 2.81 | 21.55 | 0.13 | 0.05 | 0.0 | 120.87 |
Danaher Corp. | 41.86 | 41.86 | 3.13 | 7.62 | 0.08 | 0.04 | 0.0 | 72.36 |
Iqvia Holdings Inc. | 32.69 | 32.69 | 1.33 | 11.11 | 0.23 | 0.05 | NA | 33.67 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Radnet Inc | Buy | $3.5B | 298.61% | 953.0 | 0.19% |
Idexx Laboratories, Inc. | Buy | $39.8B | 119.88% | 47.62 | 23.08% |
Agilent Technologies Inc. | Buy | $39.2B | 83.67% | 32.04 | 18.35% |
Thermo Fisher Scientific, Inc. | Buy | $209.3B | 119.68% | 35.47 | 13.99% |
Danaher Corp. | Buy | $174.8B | 95.75% | 41.86 | 19.94% |
Iqvia Holdings Inc. | Buy | $43.4B | 75.73% | 32.69 | 9.06% |
BlackRock Inc
Vanguard Group Inc
Beck, Mack & Oliver LLC
State Street Corporation
Jb Capital Partners LP
Dimensional Fund Advisors, Inc.
radnet, inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the united states based on the number of locations and annual imaging revenue. radnet has a network of 340+ owned and/or operated outpatient imaging centers. radnet's core markets include california, delaware, maryland, new jersey, and new york. together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, radnet has a total of approximately 7,300 employees.
Organization | Radnet Inc |
Employees | 7872 |
CEO | Dr. Howard G. Berger M.D. |
Industry | Health Services |
Marqeta, Inc.
$48.96
+0.27%
Endeavor Group Holdings, Inc.
$48.96
+0.27%
Global X Nasdaq 100 Covered Call Etf
$48.96
+0.27%
Grupo Aeroportuario Del Sureste, Sabdecv
$48.96
+0.27%
Middleby Corp.
$48.96
+0.27%
Dnp Select Income Closed Fund
$48.96
+0.27%
Masonite International Corp
$48.96
+0.27%
Zillow Group, Inc. - Class C Shares
$48.96
+0.27%
Tenet Healthcare Corp.
$48.96
+0.27%